Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Elizabeth Murray a Department of
Primary Care and Population Sciences, Royal Free and University College
Medical School, University College London, London N19 3UA, b Picker Institute Europe,
Oxford OX1 1RX, c Health Economics Research Centre, University of
Oxford, Oxford OX3 7LF
Correspondence to: E Murray
elizabeth.murray{at}pcps.ucl.ac.uk
Objective:
To determine whether a decision aid on
benign prostatic hypertrophy influences decision making, health
outcomes, and resource use.
What is already known on this topic
What this study adds
Design:
Randomised controlled trial.
Setting:
33 general practices in the United Kingdom.
Participants:
112 men with benign prostatic hypertrophy.
Intervention:
Patients' decision aid consisting of an
interactive multimedia programme with booklet and printed summary.
Outcome measures:
Patients' and general
practitioners' perceptions of who made the decision, decisional
conflict scores, treatment choice and prostatectomy rate, American
Urological Association symptom scale, costs, anxiety, utility, and
general health status.
Results:
Both patients and general practitioners found the decision aid acceptable. A higher proportion of patients (32% v 4%; mean difference 28%, 95% confidence interval 14%
to 41%) and their general practitioners (46% v 25%; 21%,
3% to 40%) perceived that treatment decisions had been made mainly or
only by patients in the intervention group compared with the control
group. Patients in the intervention group had significantly lower
decisional conflict scores than those in the control group at three
months (2.3 v 2.6;
0.3,
0.5 to
0.1, P<0.01) and
this was maintained at nine months. No differences were found between
the groups for anxiety, general health status, prostatic symptoms,
utility, or costs (excluding costs associated with the video disc equipment).
Conclusions:
The decision aid reduced decisional
conflict in men with benign prostatic hypertrophy, and the patients
played a more active part in decision making. Such programmes could be delivered cheaply by the internet, and there are good arguments for
coordinated investment in them, particularly for conditions in which
patient utilities are important.
Patients want more information about their condition and treatment
options, and many want to play an active part in decision
making
The decision aid was highly acceptable to both the patients and their
general practitioners
Read all Rapid Responses